GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (XCNQ:BRAX) » Definitions » EBITDA Margin %

Braxia Scientific (XCNQ:BRAX) EBITDA Margin % : -164.23% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Braxia Scientific EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Braxia Scientific's EBITDA for the three months ended in Dec. 2023 was C$-0.81 Mil. Braxia Scientific's Revenue for the three months ended in Dec. 2023 was C$0.49 Mil. Therefore, Braxia Scientific's EBITDA margin for the quarter that ended in Dec. 2023 was -164.23%.


Braxia Scientific EBITDA Margin % Historical Data

The historical data trend for Braxia Scientific's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Braxia Scientific EBITDA Margin % Chart

Braxia Scientific Annual Data
Trend Mar21 Mar22 Mar23
EBITDA Margin %
-8,810.02 -817.15 -674.31

Braxia Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -456.03 -1,463.41 -123.67 -29.29 -164.23

Competitive Comparison of Braxia Scientific's EBITDA Margin %

For the Biotechnology subindustry, Braxia Scientific's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Braxia Scientific's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Braxia Scientific's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Braxia Scientific's EBITDA Margin % falls into.



Braxia Scientific EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Braxia Scientific's EBITDA Margin % for the fiscal year that ended in Mar. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=-12.704/1.884
=-674.31 %

Braxia Scientific's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-0.808/0.492
=-164.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Braxia Scientific  (XCNQ:BRAX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Braxia Scientific EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Braxia Scientific's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Braxia Scientific (XCNQ:BRAX) Business Description

Traded in Other Exchanges
Address
700 Bay Street, Suite 1903, Toronto, ON, CAN, M5G 1Z6
Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.

Braxia Scientific (XCNQ:BRAX) Headlines

No Headlines